September 2, 2014 — In an agreement signed in Tokyo, Elekta Japan will grant Toshiba Medical Systems Corp. (TMSC) wider distribution rights regarding linear accelerator (linac) sales. The agreement builds on a sales and marketing agreement from 2010.

Shuichi Higaki, president and managing director, Elekta Japan, said: “The existing partnership between Elekta and TMSC from 2010 has helped raise Elekta’s profile in the Japanese market. This new agreement creates significant opportunities for Elekta to further increase our customer satisfaction and become the leading supplier of oncology systems and related software solutions in Japan.”

Since Siemens’s departure from the linac market in 2011, TMSC still has an installed base of about 200 aging Siemens linear accelerators. The extended partnership opens up additional sales channels for Elekta’s linacs and software products and gives Elekta the opportunity to convert existing Siemens Lantis oncology information systems (OIS) that were sold through TMSC.

The agreement also includes the intention to develop the Elekta Support Center, a centralized customer support center with a single point of contact for all Elekta linac users in Japan. Elekta will continue to manage marketing and promotion of all Elekta products and solutions, as well as education and training and software service support.

For more information: www.elekta.com


Related Content

News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
Subscribe Now